Salud

Devicare is preparing the largest round of crowdfunding on Capital Cell

Devicare is aiming to speed up its growth and will start a 1.5 million Euro crowdfunding round on Capital Cell, the funding platform that specialises in healthcare. With a 1,000 Euro minimum ticket, the company is looking to attract small investors, sponsors, patients and people knowledgeable about innovation and health.

Devicare is a technologically-driven company dedicated […]

Devicare participates in the leading lithiasis event in Spain and presents the results of the ‘Double J’ trial

February 7th, 2019

Devicare participated in the National Meeting of the Lithiasis, Endourology, Laparoscopy and Robotics Groups (LELR), held on 24 and 25 January in Palma de Mallorca. The plenary sessions focused on the medical and surgical handling of urinary lithiasis which affects 10% of the Spanish population. The final results of the “Double J” clinical […]

Devicare announces the positive results of the clinical trial with Lit-Control® to prevent the encrustation of catheters in patients with lithiasis

Devicare and nine leading Spanish hospitals in urology have successfully completed the clinical trial which demonstrates the efficacy of the combined use of a medical device (Lit-Control® pH Meter) and a nutraceutical (Lit-Control® pH Down) to prevent the encrustation of double J catheters by monitoring urinary pH and supplying phytates (crystallisation inhibitors).

The results of this […]

Dr Carlos Torrecilla: “We have the solution to prevent the encrustation of double J catheters”

Interview

December 12, 2018

Dr Carlos Torrecilla, director of the Lithiasis Unit of the Bellvitge University Hospital and national coordinator of the Lithiasis and Endourology Group of the Spanish Association of Urology, is the principal investigator of a clinical trial sponsored by Devicare conducted in nine Spanish university hospitals (Bellvitge, La Paz, Río Hortega, Puigvert Foundation, San […]

Devicare and Exeltis signed an agreement to market the Lit-Control in Spain

The multinational company Exeltis and the digital therapeutics company Devicare have signed an agreement to market the Lit-Control® family of products in Spain. Lit-Control® is the world’s first digital therapeutics solution that allows the most common urological diseases to be prevented and treated effectively from home while also improving patients’ adherence to the treatment.

This collaboration […]

Devicare and Allegra join forces to improve control of chronic illnesses in the elderly

Devicare has signed a collaboration agreement with the Allegra Residential Complex in Sabadell, Barcelona in order to offer Lit-Control® and Tao-Control® to its residents.

These two innovative services will allow users of the nursing home (161 beds), rental apartments (27 beds) and the day centre who suffer from long-term urological diseases, such as recurrent urinary tract […]

(ESP) Los avances de las terapias génicas y celulares dar respuestas a viejos problemas médicos.

(ESP) La semana pasada, se celebró la 10ª Reunión Internacional sobre Investigación Traslacional y Medicina Personalizada, en la Fundación Jiménez Díaz de Madrid. En ella, se han presentado algunos de los más importantes avances registrados en España gracias a la biomedicina con terapias génicas y celulares.

(ESP) El trasplante de células madre se presenta como alternativa a la insulina para la diabetes

(ESP) La diabetes es una de las enfermedades crónicas más comunes, además suele ser causante de otras patologías, por ello todos los avances en la investigación de la diabetes repercutirá en otras áreas. Recientemente se ha descubiertos que una combinación de un trasplante de células madre humanas y fármacos antidiabéticos ha demostrado ser muy eficaz en el control peso corporal y el metabolismo de la glucosa en un modelo de ratón de la diabetes tipo 2.

(ESP) Nuevo avance para crear tratamientos menos invasivos

(ESP) Científicos japoneses de la Universidad de Osaka han desarrollado una célula artificial híbrida que combina células pluripotentes inducidas (iPS) con células nerviosas artificiales, y que podría ayudar a desarrollar tratamientos menos invasivos que los actuales.

(ESP) Gran paso en la detección del alzhéimer con una simple prueba

(ESP) Desde Devicare trabajamos para ofrecer las mejoras soluciones para las enfermedades crónicas, intentando siempre facilitar la vida del paciente. Por ello, consideramos esta noticia muy importante: Una investigación conjunta de la empresa Neuron Bio y los hospitales granadinos Virgen de las Nieves y Clínico a los madrileños La Paz y Ramón y Cajal, han logrado que se diagnostique el alzhéimer con un análisis de sangre.